BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8775258)

  • 1. Rectosigmoid complications of radiotherapy in stage 3B carcinoma of the cervix.
    Vyas RK; Dixit S; Singhal S; Baboo HA; Aurora DC; Venkatratnam S
    Aust N Z J Obstet Gynaecol; 1996 Feb; 36(1):77-9. PubMed ID: 8775258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy.
    Cheng JC; Peng LC; Chen YH; Huang DY; Wu JK; Jian JJ
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1010-8. PubMed ID: 14575832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer of the uterine cervix: dosimetric guidelines for prevention of late rectal and rectosigmoid complications as a result of radiotherapeutic treatment.
    Pourquier H; Dubois JB; Delard R
    Int J Radiat Oncol Biol Phys; 1982 Nov; 8(11):1887-95. PubMed ID: 6818192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal complications in patients with carcinoma of the cervix treated with concomitant cisplatin and external beam irradiation with high dose rate brachytherapy: a dosimetric analysis.
    Clark BG; Souhami L; Roman TN; Evans MD; Pla C
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1243-50. PubMed ID: 8175412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder and rectal complications following radiotherapy for cervix cancer.
    Stryker JA; Bartholomew M; Velkley DE; Cunningham DE; Mortel R; Craycraft G; Shafer J
    Gynecol Oncol; 1988 Jan; 29(1):1-11. PubMed ID: 3338655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A report of late rectosigmoid morbidity in patients with advanced cancer of the cervix, treated by a six week pelvic brick technique.
    Quilty PM
    Clin Radiol; 1988 May; 39(3):297-300. PubMed ID: 3135141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of correlation between rectal complications and rectal dose following high dose rate intracavitary radiotherapy in patients with uterine cervix cancer: in vivo dosimetric analysis.
    Shin KH; Huh SJ; Chie EK; Choi DR; Lim DH; Kim MK; Lee KC; Kim DY; Ahn YC
    Radiat Med; 1999; 17(4):289-93. PubMed ID: 10510902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation.
    Perez CA; Grigsby PW; Lockett MA; Chao KS; Williamson J
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):855-66. PubMed ID: 10386643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between in vivo dosimetry and barium contrast technique for prediction of rectal complications in high-dose-rate intracavitary radiotherapy in cervix cancer patients.
    Huh SJ; Lim DH; Ahn YC; Lee JE; Kang MK; Shin SS; Shin KH; Kim B; Park W; Han Y
    Strahlenther Onkol; 2003 Mar; 179(3):191-6. PubMed ID: 12627263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix.
    Clark BG; Souhami L; Roman TN; Chappell R; Evans MD; Fowler JF
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):989-93. PubMed ID: 9276363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder and intestinal injuries following intracavitary irradiation of carcinoma of the uterine cervix.
    Friberg LG; Johsson JE
    Acta Radiol Ther Phys Biol; 1974 Aug; 13(4):288-96. PubMed ID: 4451145
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications.
    Perez CA; Breaux S; Bedwinek JM; Madoc-Jones H; Camel HM; Purdy JA; Walz BJ
    Cancer; 1984 Jul; 54(2):235-46. PubMed ID: 6722748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of dose in outcome of irradiation alone in carcinoma of the uterine cervix: analysis of two different methods.
    Perez CA; Fox S; Lockett MA; Grigsby PW; Camel HM; Galakatos A; Kao MS; Williamson J
    Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):885-98. PubMed ID: 1917616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT-based 3D dose-volume parameter of the rectum and late rectal complication in patients with cervical cancer treated with high-dose-rate intracavitary brachytherapy.
    Kato S; Tran DN; Ohno T; Nakano T; Kiyohara H; Ohkubo Y; Kamada T
    J Radiat Res; 2010; 51(2):215-21. PubMed ID: 20339256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prediction of late rectal complications following the treatment of uterine cervical cancer by high-dose-rate brachytherapy.
    Chen SW; Liang JA; Yang SN; Liu RT; Lin FJ
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):955-61. PubMed ID: 10863065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma of the uterine cervix. II. Lack of impact of prolongation of overall treatment time on morbidity of radiation therapy.
    Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):3-11. PubMed ID: 12118562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
    Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
    Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracavitary dosimetry for carcinoma of the cervix and subsequent complications.
    Buchler DA; Kline JC; Carr WF
    Am J Obstet Gynecol; 1974 Sep; 120(1):83-90. PubMed ID: 4846171
    [No Abstract]   [Full Text] [Related]  

  • 19. High dose rate brachytherapy for carcinoma of the cervix: risk factors for late rectal complications.
    Uno T; Itami J; Aruga M; Kotaka K; Fujimoto H; Sato T; Minoura S; Ito H
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):615-21. PubMed ID: 9486611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
    Lee SW; Suh CO; Chung EJ; Kim GE
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.